Log In
person
Ambrx Biopharma Inc
AMAM
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Biologics |
Patent Licensing to Drug Manufacturers
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
5.26M | 71.09% |
| Biologics |
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
2.14M | 28.91% |
| keyboard_arrow_down |
Biologics
Patent Licensing to Drug Manufacturers
|
5.26M | 71.09% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Biologics
Pharmaceutical Contract Developer and Manufacturing Organizations (CDMOs)
|
2.14M | 28.91% |
| keyboard_arrow_right |
These companies, commonly known as CDMOs, provide specialized services for drug manufacturers, such as drug discovery, research, development, and manufacturing.
|
||